Document Type



Media is loading

Publication Date



Robert Carey
Professor of Medicine
Dean, Emeritus, School of Medicine
University of Virginia

An internationally recognized leader in endocrinology, Dr. Carey has focused his clinical interest in cardiovascular endocrinology, adrenal disorders and hypertension and his research on the hormonal control of blood pressure and hypertension. Major discoveries include the first identification and characterization of the intrarenal renin-angiotensin system and the intrarenal dopaminergic system as independent tissue hormonal systems, the tissue distribution and functions of the dopamine D1-like receptor family and the angiotensin type-2 (AT2) receptor and the role of renal cyclic GMP in the control of sodium excretion and blood pressure. Dr. Carey also documented the first case of ectopic corticotropin releasing hormone as a cause of Cushing’s syndrome.

Dr. Carey served as Dean of the University of Virginia School of Medicine from 1986 to 2002. During his tenure as Dean, Dr. Carey founded departments of public health sciences, emergency medicine, radiation oncology and physical medicine and rehabilitation. He initiated the clinical trials center, the biomedical ethics center, the humanities in medicine program, the generalist medicine program, the global health program, the digestive health center of excellence and the clinical cancer center. He developed new research centers in cell signaling, structural biology, retrovirology, reproduction, immunology and cardiovascular sciences. Dr. Carey constructed four new research buildings and a conference center and developed architectural plans and funding for a fifth research building for the School of Medicine. During his 16 years as Dean, National Institutes of Health (NIH) funds to the School of Medicine quintupled, private fund raising increased 12-fold and 60 endowed professorships were established.

American College of Medical Quality

  • President, American College of Medical Quality (ACMQ)
  • Lead Co-Author of ACC/AHA 2017 Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults
  • Chair, ACC/AHA Performance Measures Writing Committee for High Blood Pressure (Published November 12, 2020 in JACC and Circulation QCOR)
  • Adjunct Faculty, Jefferson College of Population Health
  • Faculty, Rush Medical College
  • Affiliate Faculty, University of Minnesota Institute for Health Informatics

Yvonne Commodore-Mensah, PhD, MHS, RN
Assistant Professor

Johns Hopkins School of Nursing

Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology

Dr. Yvonne Commodore-Mensah is a Fellow of the American Academy of Nursing and American Heart Association (AHA). She served on the writing committee of the 2019 American College of Cardiology/AHA Clinical Performance and Quality Measures for Adults with High Blood Pressure. She is currently a member of the organizing committee of the National Hypertension Control Roundtable®.

Alison P. Smith, MPH, BA, BSN, RN
Program Director, AHA-AMA Initiative to Control Blood Pressure
American Heart Association / American Medical Association

With 25+ years working from bedside to board room, Alison Smith currently serves in a jointly held position with the American Heart Association (AHA) and the American Medical Association (AMA) as Program Director for the AHA-AMA Initiative to Control Blood Pressure. The Target: BP Program is a national effort to improve blood pressure control through a constellation of efforts to raise public awareness, improve the accuracy of blood pressure measurement, encourage providers to act rapidly, and promote partnerships with patients to engage in healthy living.

Prior to joining the AHA-AMA, Ms. Smith served for a decade as a Vice-President of Strategic Initiatives and a Senior Advisor and Consultant to C-Change, a national not-for-profit, focused on research, practice, and policy issues in cancer. Her portfolio of projects included efforts to accelerate research through regulatory reform, strengthen the cancer workforce with career promotion and cancer competency training, elevate cancer prevention through multi-sector leadership, and reduce cancer health disparities through state, tribe, and territory cancer control efforts.


High Blood Pressure (HBP) is a major risk factor for cardiovascular disease and related mortality, with recent estimates that show that 46% (or 116 million) of US adults have HBP.

Despite strong guideline-based recommendations for the accurate diagnosis and effective treatment of HBP, existing quality measures for BP control have not changed over the past several years, and now may be worsening during the COVID-19 pandemic.

Internationally recognized experts will discuss urgent imperatives for a new, cross-cutting “Blueprint for Change”, calling on leaders of health systems, payers, public health and technology companies to work collaboratively to measurably improve Guideline-based through a new system of care delivery for the many Americans with HBP.

Co-sponsored with: AJMQ and ACMQ

Presentation: 1:00:36